Projects per year
Personal profile
Biography
Professor Nancy Y. IP, SBS, BBS, MH, JP
Professor Ip is the President of The Hong Kong University of Science and Technology (HKUST) and the Morningside Professor of Life Science. Taking office in October 2022, she is the first female president of a publicly funded university in Hong Kong.
Professor Ip received her PhD degree in Pharmacology from Harvard University, after which she held the position of Senior Staff Scientist at Regeneron Pharmaceuticals Inc. in New York. Since joining HKUST in 1993, she has served as the Vice-President for Research and Development, the Dean of Science, and the Head of Biochemistry.
Professor Ip is world-renowned for her significant contributions to the field of neuroscience, for example, in understanding the complex mechanisms that underlie proper brain functions, as well as drug discovery for neurodegenerative diseases. Her outstanding research has resulted in over 330 scientific papers, that have garnered more than 45,200 SCI citations, as well as over 70 patents.
As a distinguished neuroscientist, Professor Ip has been elected to various academies, including the Chinese Academy of Sciences, the US National Academy of Sciences, the American Academy of Arts and Sciences, the World Academy of Sciences, and the Hong Kong Academy of Sciences. She is a recipient of numerous awards and honors including the National Natural Science Awards, the L’OREAL-UNESCO for Women in Science Award, and the 10 Science Stars of China by Nature.
In addition to conducting pioneering neuroscience research, Professor Ip helps shape research policy on a global level. She is a member of various strategic initiatives such as the Leadership Group of the Davos Alzheimer’s Collaborative. She also actively serves on local committees, such as the Chief Executive’s Council of Advisers, to help steer the strategic development of Hong Kong. Moreover, as the Council Chair and founding member of the Greater Bay Area Association of Academicians, she fosters cooperation among academics in Hong Kong and the Mainland, to help advance science and technology in the Greater Bay Area.
Position Held
Director of State Key Laboratory of Nervous System Disorders
Research interests
Biological Sciences - Neuroscience
Related documents
Education/Academic qualification
PhD in Pharmacology, PhD, Harvard University
1983
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
-
SDG 3 Good Health and Well-being -
SDG 5 Gender Equality -
SDG 9 Industry, Innovation, and Infrastructure -
SDG 10 Reduced Inequalities
Fingerprint
Dive into the research topics where Nancy Yuk-Yu IP is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Neuropsychiatric symptoms in cognitive progression and Alzheimer’s disease Continuum: biomarker discovery using plasma proteomics
WONG, H. Y. (CoI), FU, K. Y. (CoI), IP, N.Y.-Y. (PI), JIANG, Y. (CoI) & ZUO, L. (CoI)
Shanghai Medical Innovation & Development Foundation
1/06/26 → 31/05/30
Project: Research
-
Neuroimmune Mechanisms and Modulation in Alzheimer’s Disease
WU, A. R. (CoI), FU, K. Y. (CoPI), IP, N.Y.-Y. (CoPI), ZHU, B. D. (CoI), QU, J. (CoI), BU, G. (PI), LING, G. S. (CoI), CHOW, H. M. (CoI), KO, H. (CoPI), IP, Y. M. B. (CoI), WANG, J. (CoPI), LIU, K. (CoPI), LUI, K.O.-L. (CoPI), WANG, S. (CoPI) & MOK, V. C. T. (CoI)
RGC - Theme-based Research Scheme
1/01/26 → 31/12/30
Project: Research
-
Deciphering the Factors of Longevity through a Multi-Omics Study in Long-Lived Individuals in Hong Kong
WONG, H. Y. (CoPI), FU, K. Y. (CoPI), IP, F. C. F. (CoPI), IP, N.Y.-Y. (PI) & MOK, K. Y. B. (CoPI)
Bright Future Charitable Foundation Limited
1/12/25 → 31/12/29
Project: Research
-
NeuroCare Community Project
FU, K. Y. (CoI), IP, N.Y.-Y. (PI), WONG, W. Y. (CoI), WONG, J.C.-H. (CoI), MOK, K. Y. B. (CoPI), KWAN, R. (CoI), LAM, S. (CoI) & CHEUNG, T. (CoI)
1/10/25 → 30/09/30
Project: Research
-
The NeuroCare Community Project – Revolutionizing Early Alzheimer's Disease Detection
FU, K. Y. (CoI), IP, N.Y.-Y. (PI), WONG, W. Y. (CoI), WONG, J.C.-H. (CoI), MOK, K. Y. B. (CoPI), LAM, S. (CoI), CHEUNG, T. (CoI) & KWAN, R. (CoI)
1/07/25 → 30/06/30
Project: Research
-
A modernised fluorescent silver method for 3D brain histology using an AIE fluorogenic probe
Xie, S., Wong, A. Y. H., Kam, C., Hermanson, O., Ip, N. Y., Tang, B. Z. & Chen, S., Jun 2026, In: Science China Chemistry. 69, 6, p. 3145-3152 8 p.Research output: Contribution to journal › Journal Article › peer-review
Open Access1 Link opens in a new tab Citation (Scopus) -
Association of LRRK2 p.A419V with Parkinson’s Disease in East Asians and analysis of age at onset
The Global Parkinson’s Genetics Program (GP2), Ip, N., CHAN, Y. C. P., Zhou, X. & Mok, K. Y., Dec 2026, In: npj Parkinson's Disease. 12, 1, 12 p., 51.Research output: Contribution to journal › Journal Article › peer-review
Open Access -
Author Correction: TMEM175, SCARB2 and CTSB associations with Parkinson’s disease risk across populations (npj Parkinson's Disease, (2025), 11, 1, (348), 10.1038/s41531-025-01180-z)
the Global Parkinson’s Genetic Program (GP2) & CHAN, P. C. H., 13 Apr 2026, In: npj Parkinson's Disease. 12, 1, 1 p., 93.Research output: Contribution to journal › Erratum
Open Access -
DeepPlaque: a scalable multimodal platform for Aβ pathology and cell analysis in Alzheimer’s disease
Wong, H. Y., Jin, C., Yuen, S. L., Yang, X., Gill, S. S., Xu, J., Lai, K. P. E., Fu, W. Y., Gao, W., Wang, X., Wang, J., Cao, H., Lv, G., Mok, K. Y., Tian, R., Fu, A. K. Y., Chen, H. & Ip, N. Y., 21 Jul 2026, In: EMBO Molecular Medicine. 22 p.Research output: Contribution to journal › Journal Article › peer-review
Open Access -
Ethnic-specific effects of the LILRB2–LILRB5 locus and newly identified risk loci for Alzheimer's disease in the East Asian population
Japanese Alzheimer's Disease Neuroimaging Initiative & Alzheimer's Disease Neuroimaging Initiative, Feb 2026, In: Alzheimer's and Dementia. 22, 2, 16 p., e71219.Research output: Contribution to journal › Journal Article › peer-review
Open Access
-
Understanding the biomarkers of Alzheimer’s Disease – Insights into the Development of Diagnostics and Therapeutics
IP, N.Y.-Y. (Invited speaker)
19 Sept 2025Activity: Talk or presentation › Invited
-
Journal of Alzheimer's Diseases (Journal)
IP, N.Y.-Y. (Editor)
1 Jan 2021 → 1 Dec 2022Activity: Publication peer-review and editorial work › Editorial work
-
Neurobiology of Diseases (Journal)
IP, N.Y.-Y. (Editorial Board Member)
1 Jan 2020 → 1 Jan 2022Activity: Publication peer-review and editorial work › Editorial work
-
Proceeding of National Academy of Sciences (Journal)
IP, N.Y.-Y. (Editorial Board Member)
1 Jan 2017 → 1 Jan 2022Activity: Publication peer-review and editorial work › Editorial work
-
Current Opinion in Neurobiology (Journal)
IP, N.Y.-Y. (Editorial Board Member)
1 Jan 2017 → 1 Jan 2022Activity: Publication peer-review and editorial work › Editorial work
Awards
-
Honorary doctorate from the University of Strathclyde
IP, N.Y.-Y. (Recipient), 30 Oct 2025
Prize: Honorary Award
-
Gold Meal with Congratulations of the Jury and Prize of the Chinese Delegation for Invention and Innovation
IP, N.Y.-Y. (Recipient), Apr 2024
Prize: Other Research Award and Prize
-
-
Women-in-STEM Groundbreakers Award for Leadership
IP, N.Y.-Y. (Recipient), Nov 2024
Prize: Honorary Award
-